Debilitating chronic fatigue syndrome creates conditions where a kind of immune cell that identifies and kills pathogens, ...

While early and from a small trial, the findings suggest Janux’s method of “masking” T cell engagers could lead to ...

Debilitating chronic fatigue syndrome creates conditions where a kind of immune cell that identifies and kills pathogens, known as a T cell, becomes ...

Recent research has unveiled that DNA secreted by tumor cells through extracellular vesicles (EVs) can stimulate an immune response that helps inhibit the spread of tumors to the liver. This ...

A randomized controlled trial found that carrageenan, a common food additive, may cause subclinical inflammation and insulin ...

REHOVOT, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- (“Purple Biotech” or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage ...

Janux Therapeutics' TRACTr platform shows promise with encouraging early data. Check out what leads me to maintain a “Strong ...

Researchers find that SARS-CoV-2 spike protein persists in the skull-meninges-brain axis, driving neuroinflammation, ...

Jean C. Pfau, Ph.D. and Kinta Serve provide their perspective on asbestos, the pleural cavity, and autoimmune disease ...

Researchers stimulated the vagus nerve in healthy volunteers and showed it triggered blood clot formation, which they say ...

Tebentafusp is the first treatment of its kind for uveal melanoma, which develops from cells in the middle layer of the eye, ...

This means taking NAD supplements resulted in small improvements in muscle function, but it didn't necessarily increase ...